Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2020

Open Access 01-12-2020 | Coronary Heart Disease | Research article

Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin

Authors: Takuya Kawahara, Tomohiro Shinozaki, Yutaka Matsuyama

Published in: BMC Medical Research Methodology | Issue 1/2020

Login to get access

Abstract

Background

In the presence of dependent censoring even after stratification of baseline covariates, the Kaplan–Meier estimator provides an inconsistent estimate of risk. To account for dependent censoring, time-varying covariates can be used along with two statistical methods: the inverse probability of censoring weighted (IPCW) Kaplan–Meier estimator and the parametric g-formula estimator. The consistency of the IPCW Kaplan–Meier estimator depends on the correctness of the model specification of censoring hazard, whereas that of the parametric g-formula estimator depends on the correctness of the models for event hazard and time-varying covariates.

Methods

We combined the IPCW Kaplan–Meier estimator and the parametric g-formula estimator into a doubly robust estimator that can adjust for dependent censoring. The estimator is theoretically more robust to model misspecification than the IPCW Kaplan–Meier estimator and the parametric g-formula estimator. We conducted simulation studies with a time-varying covariate that affected both time-to-event and censoring under correct and incorrect models for censoring, event, and time-varying covariates. We applied our proposed estimator to a large clinical trial data with censoring before the end of follow-up.

Results

Simulation studies demonstrated that our proposed estimator is doubly robust, namely it is consistent if either the model for the IPCW Kaplan–Meier estimator or the models for the parametric g-formula estimator, but not necessarily both, is correctly specified. Simulation studies and data application demonstrated that our estimator can be more efficient than the IPCW Kaplan–Meier estimator.

Conclusions

The proposed estimator is useful for estimation of risk if censoring is affected by time-varying risk factors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Prog Biomed. 2004;75:45–9.CrossRef Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Prog Biomed. 2004;75:45–9.CrossRef
2.
go back to reference Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24:3089–110.CrossRef Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24:3089–110.CrossRef
3.
go back to reference Shinozaki T, Matsuyama Y. Doubly robust estimation of standardized risk difference and ratio in the exposed population. Epidemiology. 2015;26:873–7.CrossRef Shinozaki T, Matsuyama Y. Doubly robust estimation of standardized risk difference and ratio in the exposed population. Epidemiology. 2015;26:873–7.CrossRef
4.
go back to reference Komukai S, Hattori S. Doubly robust estimator for net survival rate in analyses of cancer registry data. Biometrics. 2017;73:124–33.CrossRef Komukai S, Hattori S. Doubly robust estimator for net survival rate in analyses of cancer registry data. Biometrics. 2017;73:124–33.CrossRef
5.
go back to reference Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA study): a prospective randomised controlled trial. Lancet. 2006;368:1155–63.CrossRef Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA study): a prospective randomised controlled trial. Lancet. 2006;368:1155–63.CrossRef
6.
go back to reference Kleinbaum DG, Klein M. Survival analysis—a self learning text. 2nd ed. New York: Springer; 2005. Kleinbaum DG, Klein M. Survival analysis—a self learning text. 2nd ed. New York: Springer; 2005.
7.
go back to reference Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000;56:779–88.CrossRef Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000;56:779–88.CrossRef
8.
go back to reference Stitelman OM, De Gruttola V, van der Laan MJ. A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis. Int J Biostat. 2012;8:1–37. Stitelman OM, De Gruttola V, van der Laan MJ. A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis. Int J Biostat. 2012;8:1–37.
9.
go back to reference Bang H, Robins JM. Doubly robust estimation in missing data and causal inference models. Biometrics. 2005;61:962–72.CrossRef Bang H, Robins JM. Doubly robust estimation in missing data and causal inference models. Biometrics. 2005;61:962–72.CrossRef
10.
go back to reference Schnitzer ME, van der Laan MJ, Moodie EEM, Platt RW. Effect of breastfeeding on gastrointestinal infection in infants : a targeted maximum likelihood. Ann Appl Stat. 2014;8:703–25.CrossRef Schnitzer ME, van der Laan MJ, Moodie EEM, Platt RW. Effect of breastfeeding on gastrointestinal infection in infants : a targeted maximum likelihood. Ann Appl Stat. 2014;8:703–25.CrossRef
11.
go back to reference Petersen M, Schwab J, Gruber S, Blaser N, Schomaker M, van der Laan MJ. Targeted maximum likelihood estimation for dynamic and static longitudinal marginal structural working models. J Causal Inference. 2014;2:147–85.CrossRef Petersen M, Schwab J, Gruber S, Blaser N, Schomaker M, van der Laan MJ. Targeted maximum likelihood estimation for dynamic and static longitudinal marginal structural working models. J Causal Inference. 2014;2:147–85.CrossRef
12.
go back to reference Schnitzer ME, Lok JJ, Bosch RJ. Double robust and efficient estimation of a prognostic model for events in the presence of dependent censoring. Biostatistics. 2016;17:165–77.PubMed Schnitzer ME, Lok JJ, Bosch RJ. Double robust and efficient estimation of a prognostic model for events in the presence of dependent censoring. Biostatistics. 2016;17:165–77.PubMed
13.
go back to reference Robins J. The control of confounding by intermediate variables. Stat Med. 1989;8:679–701.CrossRef Robins J. The control of confounding by intermediate variables. Stat Med. 1989;8:679–701.CrossRef
14.
go back to reference Westreich D, Edwards JK, Cole SR, Platt RW, Mumford SL, Schisterman EF. Imputation approaches for potential outcomes in causal inference. Int J Epidemiol. 2015;44:1731–7.CrossRef Westreich D, Edwards JK, Cole SR, Platt RW, Mumford SL, Schisterman EF. Imputation approaches for potential outcomes in causal inference. Int J Epidemiol. 2015;44:1731–7.CrossRef
15.
go back to reference Wang A, Nianogo RA, Arah OA. G-computation of average treatment effects on the treated and the untreated. BMC Med Res Methodol. 2017;17:3.CrossRef Wang A, Nianogo RA, Arah OA. G-computation of average treatment effects on the treated and the untreated. BMC Med Res Methodol. 2017;17:3.CrossRef
16.
go back to reference Taubman SL, Robins JM, Mittleman MA, Hernán MA. Intervening on risk factors for coronary heart disease : an application of the parametric g-formula. Int J Epidemiol. 2009;38:1599–611.CrossRef Taubman SL, Robins JM, Mittleman MA, Hernán MA. Intervening on risk factors for coronary heart disease : an application of the parametric g-formula. Int J Epidemiol. 2009;38:1599–611.CrossRef
17.
go back to reference Lunceford JK, Davidian M. Stratifcation and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med. 2004;23:2937–60.CrossRef Lunceford JK, Davidian M. Stratifcation and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med. 2004;23:2937–60.CrossRef
18.
go back to reference Tsiatis AA. Semiparametric theory and missing data. New York: Springer; 2006. Tsiatis AA. Semiparametric theory and missing data. New York: Springer; 2006.
19.
go back to reference Kang JDY, Schafer JL. Demystifying double robustness: a comparison of alternative strategies for estimating a population mean from incomplete data. Stat Sci. 2007;22:523–39.CrossRef Kang JDY, Schafer JL. Demystifying double robustness: a comparison of alternative strategies for estimating a population mean from incomplete data. Stat Sci. 2007;22:523–39.CrossRef
20.
go back to reference Satten GA, Datta S. The Kaplan-Meier estimator as an inverse-probability-of-censoring weighted average. Am Stat. 2001;55:207–10.CrossRef Satten GA, Datta S. The Kaplan-Meier estimator as an inverse-probability-of-censoring weighted average. Am Stat. 2001;55:207–10.CrossRef
21.
go back to reference Westreich D, Cole SR, Young JG, Palella F, Tien PC, Kingsley L, et al. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2012;31:2000–9.CrossRef Westreich D, Cole SR, Young JG, Palella F, Tien PC, Kingsley L, et al. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2012;31:2000–9.CrossRef
22.
go back to reference Young JG, Cain LE, Robins JM, O’Reilly EJ, Hernán MA. Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci. 2011;3:119–43.CrossRef Young JG, Cain LE, Robins JM, O’Reilly EJ, Hernán MA. Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci. 2011;3:119–43.CrossRef
23.
go back to reference Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993.CrossRef Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993.CrossRef
24.
go back to reference Zhang M, Schaubel DE. Contrasting treatment-specific survival using double-robust estimators. Stat Med. 2012;31:4255–68.CrossRef Zhang M, Schaubel DE. Contrasting treatment-specific survival using double-robust estimators. Stat Med. 2012;31:4255–68.CrossRef
25.
go back to reference Bai X, Tsiatis AA, O’Brien SM. Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling. Biometrics. 2013;69:830–9.CrossRef Bai X, Tsiatis AA, O’Brien SM. Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling. Biometrics. 2013;69:830–9.CrossRef
26.
27.
go back to reference Hernán MA, Robins JM. Causal inference: what if. Chapman & Hall/CRC: Boca Raton; 2020. Hernán MA, Robins JM. Causal inference: what if. Chapman & Hall/CRC: Boca Raton; 2020.
28.
go back to reference Yoshida M, Matsuyama Y, Ohashi Y, For the MEGA study group. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study). Clin Trials. 2007;4:318–28.CrossRef Yoshida M, Matsuyama Y, Ohashi Y, For the MEGA study group. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study). Clin Trials. 2007;4:318–28.CrossRef
Metadata
Title
Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin
Authors
Takuya Kawahara
Tomohiro Shinozaki
Yutaka Matsuyama
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2020
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-020-01087-8

Other articles of this Issue 1/2020

BMC Medical Research Methodology 1/2020 Go to the issue